Is a complete STLN research report available?

No complete published report is available for Starling Oncology, Inc. (STLN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Starling Oncology, Inc. (STLN)

NASDAQ: STLN · USD

$6.64

+0.05 (+0.8%)· Recorded snapshot

Market cap	676.7M
Revenue (ttm)	587.2M
Net income (ttm)	-30.6M
EPS (ttm)	-$0.30
Shares out	101.9M
Volume	968,403
Beta	0.42

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 587.2M
Net income (ttm): -30.6M
EPS (ttm): -$0.30
Market cap: 676.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Metric	Value
Amount currency	USD
CIK code	0001799191
Company name	Starling Oncology, Inc.
Country	United States
Country code	US
CUSIP number	68236X100
Earnings date	2026-11-05
Earnings time	amc
Employees	641
Employees change	-184
Employees growth	-22.3%
Enterprise value	$740.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-08-05
Fiscal year end	December
Founded	2007
In index	RUSSELL2000
Industry	Medical Care Facilities
Is primary listing	Yes
Is SPAC	No
ISIN number	US68236X1000
Last 10-K release date	2026-03-12
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$676.7M
Market cap category	Small-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$6.64
Price currency	USD
Sector	Healthcare
SIC code	8011
Stock price date	2026-10-28
Symbol	STLN
U.S. state	California
Website	https://starlingoncology.com

Metric

Value

Amount currency

USD

CIK code

0001799191

Company name

Starling Oncology, Inc.

Country

United States

Country code

CUSIP number

68236X100

Earnings date

2026-11-05

Earnings time

amc

Employees

641

Employees change

-184

Employees growth

-22.3%

Enterprise value

$740.4M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-08-05

Fiscal year end

December

Founded

2007

In index

RUSSELL2000

Industry

Medical Care Facilities

Is primary listing

Yes

Is SPAC

ISIN number

US68236X1000

Last 10-K release date

2026-03-12

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$676.7M

Market cap category

Small-Cap

Next earnings date

2026-11-05

Options

Yes

Price

$6.64

Price currency

USD

Sector

Healthcare

SIC code

8011

Stock price date

2026-10-28

Symbol

STLN

U.S. state

California

Website

https://starlingoncology.com

Metric	Value
Earnings yield	-4.58%
EV/Sales	1.28x
FCF / EV yield	-0.44%
FCF yield	-0.48%
Forward EV/Sales	0.98x
Forward P/S	0.9x
Industry forward P/E	14.95x
Industry P/E	18.37x
P/OCF ratio	2,094.25x
P/S ratio	1.17x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-4.58%

EV/Sales

1.28x

FCF / EV yield

-0.44%

FCF yield

-0.48%

Forward EV/Sales

0.98x

Forward P/S

0.9x

Industry forward P/E

14.95x

Industry P/E

18.37x

P/OCF ratio

2,094.25x

P/S ratio

1.17x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	-4.44%
EBITDA margin	-3.28%
Gross margin	15.69%
Operating margin	-4.44%
Pretax margin	-6.18%
Profit margin	-6.18%
Profit per employee	$-47,680
Revenue per employee	$916,137
ROA	-9.65%
ROA (5Y)	-17.89%
ROCE	-31.32%
ROIC	-30.31%
SBC / revenue	0.87%

Metric

Value

EBIT margin

-4.44%

EBITDA margin

-3.28%

Gross margin

15.69%

Operating margin

-4.44%

Pretax margin

-6.18%

Profit margin

-6.18%

Profit per employee

$-47,680

Revenue per employee

$916,137

ROA

-9.65%

ROA (5Y)

-17.89%

ROCE

-31.32%

ROIC

-30.31%

SBC / revenue

0.87%

Metric	Value
EPS growth quarters	10
EPS growth years	2
Gross profit growth	44.57%
Gross profit growth (Q)	55.22%
Gross profit growth 3Y	16.8%
Gross profit growth 5Y	17.3%
Net income growth quarters	3
Net income growth years	2
Revenue growth	38.38%
Revenue growth (Q)	34.62%
Revenue growth (QoQ)	9.39%
Revenue growth 3Y	26.11%
Revenue growth 5Y	24.71%
Revenue growth quarters	21
Revenue growth years	6

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

44.57%

Gross profit growth (Q)

55.22%

Gross profit growth 3Y

16.8%

Gross profit growth 5Y

17.3%

Net income growth quarters

Net income growth years

Revenue growth

38.38%

Revenue growth (Q)

34.62%

Revenue growth (QoQ)

9.39%

Revenue growth 3Y

26.11%

Revenue growth 5Y

24.71%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-3.6M
Depreciation and amortization	$6.8M
EBIT	$-26.1M
EBITDA	$-19.3M
EPS	$-0.30
FCF per share	$-0.03
Financing cash flow	$14.1M
Free cash flow	$-3.3M
Free cash flow minus SBC	$-8.4M
Gross profit	$92.2M
Investing cash flow	$-3.6M
Net borrowing	$-1.1M
Net cash flow	$10.8M
Net income	$-30.6M
Operating cash flow minus SBC	$-4.8M
Operating income	$-26.1M
Revenue	$587.2M
Stock-based compensation	$5.1M

Metric

Value

Capital expenditures

$-3.6M

Depreciation and amortization

$6.8M

EBIT

$-26.1M

EBITDA

$-19.3M

EPS

$-0.30

FCF per share

$-0.03

Financing cash flow

$14.1M

Free cash flow

$-3.3M

Free cash flow minus SBC

$-8.4M

Gross profit

$92.2M

Investing cash flow

$-3.6M

Net borrowing

$-1.1M

Net cash flow

$10.8M

Net income

$-30.6M

Operating cash flow minus SBC

$-4.8M

Operating income

$-26.1M

Revenue

$587.2M

Stock-based compensation

$5.1M

Metric	Value
Altman Z-Score	1.84
Book value per share	$-0.25
Goodwill	$7.2M
Interest coverage	-3.42
Long-term assets	$49.2M
Long-term liabilities	$108.2M
Net cash (debt)	$-63.7M
Net cash / market cap	-9.27%
Piotroski F-Score	4
Property, plant and equipment	$31.8M
Shareholders' equity	$-24.9M
Tangible book value	$-41.7M
Tangible book value per share	$-0.42
Total assets	$178.2M
Total cash	$41.1M
Total debt	$104.8M
Total liabilities	$203.1M
WACC	6.45%

Metric

Value

Altman Z-Score

1.84

Book value per share

$-0.25

Goodwill

$7.2M

Interest coverage

-3.42

Long-term assets

$49.2M

Long-term liabilities

$108.2M

Net cash (debt)

$-63.7M

Net cash / market cap

-9.27%

Piotroski F-Score

Property, plant and equipment

$31.8M

Shareholders' equity

$-24.9M

Tangible book value

$-41.7M

Tangible book value per share

$-0.42

Total assets

$178.2M

Total cash

$41.1M

Total debt

$104.8M

Total liabilities

$203.1M

WACC

6.45%

Metric	Value
Asset turnover	3.47
Current assets	$129M
Current liabilities	$94.9M
Current ratio	1.36
Inventory turnover	27.66
Net working capital	$489,000
Quick ratio	1.14
Working capital	$34.1M
Working capital turnover	15.86

Metric

Value

Asset turnover

3.47

Current assets

$129M

Current liabilities

$94.9M

Current ratio

1.36

Inventory turnover

27.66

Net working capital

$489,000

Quick ratio

1.14

Working capital

$34.1M

Working capital turnover

15.86

Metric	Value
Buyback yield / dilution	-25.63%
Dividend yield	0%
Shareholder yield	-25.63%

Metric

Value

Buyback yield / dilution

-25.63%

Dividend yield

Shareholder yield

-25.63%

Metric	Value
150-day SMA	$5.24
1D price change	0.76%
1M price change	-0.9%
1M total return	-0.9%
1W price change	-0.45%
1W total return	-0.45%
1Y price change	43.17%
1Y return CAGR	43.2%
1Y total return	43.17%
20-day SMA	$6.56
200-day SMA	$4.67
3M price change	27.17%
3M total return	27.17%
3Y price change	249.21%
3Y return CAGR	51.7%
3Y total return	249.21%
50-day SMA	$6.47
50-day SMA vs 200-day SMA	50over200
52-week high	$7.13
52-week high date	2026-09-18
52-week low	$2.32
52-week low date	2026-02-13
5Y price change	-33.93%
5Y return CAGR	-7.96%
5Y total return	-33.93%
6M price change	98.2%
6M total return	98.2%
All-time high	$12.66
All-time high date	2021-12-27
All-time low	$0.13
All-time low date	2024-11-21
Average true range (ATR)	$0.38
Average volume	1.2M
Beta (1Y)	2.2
Beta (2Y)	2.1
Beta (5Y)	0.42
Change from 52-week high	-6.87%
Change from 52-week low	186.21%
Change from all-time high	-47.87%
Change from all-time low	5,167.36%
Change from open	0.76%
Day's gap	0%
Dollar volume	$6.4M
High price	$6.77
Low price	$6.52
Monthly RSI	68.46
Open price	$6.59
Position in 52-week range	48%
Premarket change	-1.21%
Premarket close	$6.59
Premarket price	$6.51
Premarket volume	1.5K
Previous close	$6.59
Price vs 150-day SMA	25.95%
Price vs 20-day SMA	0.63%
Price vs 200-day SMA	41.48%
Price vs 50-day SMA	2.01%
Relative volume	0.8
RSI	50.93
Sharpe ratio	0.78
Sharpe ratio (3Y)	0.94
Sharpe ratio (5Y)	0.43
Sortino ratio	1.41
Sortino ratio (3Y)	1.6
Sortino ratio (5Y)	0.73
Volume	968.4K
Weekly RSI	61.96
YTD price change	85.39%
YTD total return	85.39%

Metric

Value

150-day SMA

$5.24

1D price change

0.76%

1M price change

-0.9%

1M total return

-0.9%

1W price change

-0.45%

1W total return

-0.45%

1Y price change

43.17%

1Y return CAGR

43.2%

1Y total return

43.17%

20-day SMA

$6.56

200-day SMA

$4.67

3M price change

27.17%

3M total return

27.17%

3Y price change

249.21%

3Y return CAGR

51.7%

3Y total return

249.21%

50-day SMA

$6.47

50-day SMA vs 200-day SMA

50over200

52-week high

$7.13

52-week high date

2026-09-18

52-week low

$2.32

52-week low date

2026-02-13

5Y price change

-33.93%

5Y return CAGR

-7.96%

5Y total return

-33.93%

6M price change

98.2%

6M total return

98.2%

All-time high

$12.66

All-time high date

2021-12-27

All-time low

$0.13

All-time low date

2024-11-21

Average true range (ATR)

$0.38

Average volume

1.2M

Beta (1Y)

2.2

Beta (2Y)

2.1

Beta (5Y)

0.42

Change from 52-week high

-6.87%

Change from 52-week low

186.21%

Change from all-time high

-47.87%

Change from all-time low

5,167.36%

Change from open

0.76%

Day's gap

Dollar volume

$6.4M

High price

$6.77

Low price

$6.52

Monthly RSI

68.46

Open price

$6.59

Position in 52-week range

48%

Premarket change

-1.21%

Premarket close

$6.59

Premarket price

$6.51

Premarket volume

1.5K

Previous close

$6.59

Price vs 150-day SMA

25.95%

Price vs 20-day SMA

0.63%

Price vs 200-day SMA

41.48%

Price vs 50-day SMA

2.01%

Relative volume

0.8

RSI

50.93

Sharpe ratio

0.78

Sharpe ratio (3Y)

0.94

Sharpe ratio (5Y)

0.43

Sortino ratio

1.41

Sortino ratio (3Y)

1.6

Sortino ratio (5Y)

0.73

Volume

968.4K

Weekly RSI

61.96

YTD price change

85.39%

YTD total return

85.39%

Metric	Value
Float	88.9M
Float percentage	87.22%
Shares change (QoQ)	1.21%
Shares change (YoY)	25.63%
Shares held by insiders	12.78%
Shares held by institutions	49.19%
Shares outstanding	101.9M
Short % of float	7.64%
Short % of shares	6.67%
Short ratio	5.2 days

Metric

Value

Float

88.9M

Float percentage

87.22%

Shares change (QoQ)

1.21%

Shares change (YoY)

25.63%

Shares held by insiders

12.78%

Shares held by institutions

49.19%

Shares outstanding

101.9M

Short % of float

7.64%

Short % of shares

6.67%

Short ratio

5.2 days

Starling Oncology, Inc. (STLN)

Price

Financial snapshot

Fair-value bridge

Latest news · STLN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All STLN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on STLN

Frequently asked questions